—

Jones Hill Capital LP

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    26

  • Value ($000)

    $466,471

  • Date Filed
    05/14/2026
  • Form type
    13F-HR
  • CIK
    0002102314
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
B
BMRN

BIOMARIN PHARMACEUTICAL INC

COM
09061G101
$71.65M
15 %

1,268,390

V
VRTX

VERTEX PHARMACEUTICALS INC

COM
92532F100
$48.5M
10 %

108,603

P
PCVX

VAXCYTE INC

COM
92243G108
$37.47M
8 %

644,831

N
NUVL

NUVALENT INC

COM
670703107
$30.82M
7 %

300,830

C
CAPR

CAPRICOR THERAPEUTICS INC

COM NEW
14070B309
$27.64M
6 %

909,207

T
TERN

TERNS PHARMACEUTICALS INC

COM
880881107
$27.48M
6 %

521,237

---

BICARA THERAPEUTICS INC

COM
055477103
$25.06M
5 %

1,260,136

B
BSFA

ANI PHARMACEUTICALS INC

COM
00182C103
$24.5M
5 %

318,591

R
RARE

ULTRAGENYX PHARMACEUTICAL IN

COM
90400D108
$24.42M
5 %

1,165,557

E
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$23.25M
5 %

593,040

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 26